Poupak Fallahi Selected Research

Goiter

1/2021	Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism.
3/2019	The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): Review of the literature and report of a large series.
12/2016	The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Poupak Fallahi Research Topics

Disease

47	Neoplasms (Cancer) 01/2024 - 05/2003
43	Thyroid Neoplasms (Thyroid Cancer) 12/2022 - 05/2006
34	Hypothyroidism 01/2024 - 07/2004
25	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2022 - 11/2004
21	Anaplastic Thyroid Carcinoma 01/2024 - 07/2008
21	Graves Disease (Basedow Disease) 10/2023 - 02/2006
19	Cryoglobulinemia 01/2023 - 09/2008
16	Graves Ophthalmopathy 01/2023 - 02/2006
15	Infections 01/2023 - 07/2004
12	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 11/2004
12	Papillary Thyroid Cancer 12/2018 - 09/2008
11	Hyperthyroidism 02/2023 - 07/2005
10	COVID-19 12/2023 - 11/2020
9	Inflammation (Inflammations) 01/2023 - 11/2004
9	Hepatitis C 08/2013 - 09/2008
8	Thyroiditis 01/2023 - 01/2014
8	medullary Thyroid cancer 01/2022 - 06/2014
8	Persistent Infection 01/2017 - 11/2010
7	Thyroid Diseases (Thyroid Disease) 10/2023 - 09/2005
7	Fatigue 01/2021 - 06/2014
6	Hypertension (High Blood Pressure) 01/2023 - 06/2014
5	Diarrhea 01/2023 - 01/2015
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 02/2013
5	Systemic Scleroderma (Systemic Sclerosis) 12/2019 - 09/2008
5	Chronic Hepatitis C 01/2019 - 07/2004
5	Vasculitis (Vasculitides) 01/2017 - 10/2009
5	Chronic Hepatitis (Chronic Active Hepatitis) 10/2009 - 07/2004
4	Thyrotoxicosis 01/2023 - 01/2020
4	Type 2 Diabetes Mellitus (MODY) 12/2021 - 12/2002
4	Fibrosis (Cirrhosis) 01/2019 - 07/2004
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 12/2013
4	Hepatocellular Carcinoma (Hepatoma) 12/2018 - 07/2004
4	Necrosis 12/2018 - 01/2011
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 01/2012
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2017 - 01/2012
4	Heart Failure 01/2015 - 10/2009
3	Rheumatoid Arthritis 04/2024 - 03/2014
3	Lactose Intolerance (Intolerance, Lactose) 01/2024 - 01/2017
3	Malignant Mesothelioma 01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

39	ChemokinesIBA 01/2023 - 11/2004
28	CytokinesIBA 04/2024 - 02/2006
25	CXC ChemokinesIBA 01/2023 - 11/2004
22	LigandsIBA 03/2019 - 11/2004
20	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2024 - 05/2006
15	InterferonsIBA 02/2023 - 07/2004
13	AutoantibodiesIBA 10/2023 - 12/2002
12	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2024 - 09/2005
12	IodineIBA 04/2022 - 07/2004
12	Chemokine CXCL10IBA 12/2018 - 12/2009
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 10/2008
10	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2010
9	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
9	TabletsIBA 01/2021 - 02/2016
9	anti-thyroglobulinIBA 12/2016 - 07/2004
9	Interferon-gamma (Interferon, gamma)IBA 11/2010 - 11/2004
8	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 11/2014
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2012
8	AntibodiesIBA 01/2021 - 07/2004
8	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 12/2011
6	VaccinesIBA 12/2023 - 12/2021
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2022 - 04/2014
6	Thyroid HormonesIBA 01/2022 - 05/2003
6	vandetanib (ZD6474)IBA 01/2019 - 06/2014
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 07/2011
6	CC ChemokinesIBA 01/2018 - 02/2005
6	Interleukin-6 (Interleukin 6)IBA 08/2013 - 10/2009
5	Phosphotransferases (Kinase)IBA 01/2024 - 12/2011
5	SeleniumIBA 01/2022 - 01/2017
5	Inositol (Myoinositol)IBA 01/2022 - 12/2018
5	Monoclonal AntibodiesIBA 01/2022 - 12/2018
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 12/2011
5	ThiazolidinedionesIBA 01/2018 - 09/2008
5	Sorafenib (BAY 43-9006)FDA Link 03/2017 - 12/2013
5	pyrimidineIBA 07/2016 - 02/2011
5	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2014 - 06/2009
4	COVID-19 VaccinesIBA 12/2023 - 12/2021
4	Messenger RNA (mRNA)IBA 07/2022 - 01/2017
4	Rituximab (Mabthera)FDA Link 12/2021 - 11/2015
4	lenvatinibIBA 09/2021 - 01/2018
4	Insulin (Novolin)FDA Link 01/2021 - 02/2014
4	pembrolizumabIBA 01/2020 - 01/2018
4	NivolumabIBA 01/2020 - 01/2018
4	IpilimumabIBA 01/2020 - 01/2018
4	atezolizumabIBA 01/2020 - 01/2018
4	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2019 - 12/2013
4	PPAR gammaIBA 07/2019 - 02/2006
4	Rosiglitazone (Avandia)FDA Link 01/2018 - 02/2011
4	Peroxidase (Myeloperoxidase)IBA 01/2017 - 06/2010
4	ErbB Receptors (EGF Receptor)IBA 07/2016 - 04/2014
4	Iodide Peroxidase (Deiodinase)IBA 01/2009 - 07/2004
3	Thyrotropin Receptors (Thyrotropin Receptor)IBA 02/2023 - 09/2008
3	RacivirIBA 04/2022 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	AsbestosIBA 01/2022 - 01/2018

Therapy/Procedure

39	Therapeutics 02/2023 - 02/2006
7	Drug Therapy (Chemotherapy) 04/2022 - 07/2008
6	Immunotherapy 01/2023 - 01/2018
5	Thyroidectomy 01/2021 - 05/2003
4	Aftercare (After-Treatment) 04/2023 - 12/2018
4	Radiotherapy 01/2012 - 07/2008